The magnitude of an iatrogenic disorder: A systematic review of the incidence of venous thromboembolism for general medical inpatients

被引:23
作者
Dunn, Andrew S. [1 ]
Brenner, Adam [1 ]
Halm, Ethan A. [1 ]
机构
[1] Mt Sinai Sch Med, Div Gen Internal Med, Anticoagulat Serv, Dept Med, New York, NY 10029 USA
关键词
venous thromboembolism; anticoagulation; prophylaxis; deep vein thrombosis; pulmonary embolism;
D O I
10.1160/TH06-02-0089
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Venous thromboembolism (VTE) is recognized as a potential serious complication of hospitalization, and anticoagulant prophylaxis is widely recommended for medical inpatients. The purpose of this review was to systematically inspect the literature to determine the incidence of VTE without anticoagulant prophylaxis for hospitalized general medical patients. A systematic review was performed using MEDLINE and Cochrane Collaboration searches of the English-language literature. References of the retrieved articles were reviewed for additional studies, and pharmaceutical companies were contacted directly to identify unpublished studies. Studies were eligible if they reported the incidence of symptomatic or asymptomatic VTE in hospitalized general medical patients and included a group which did not receive prophylaxis. Eight trials were identified. Study design, quality, and results were heterogeneous. The incidence of symptomatic VTE without prophylaxis was examined in three trials; the incidence was 2.3% in the only randomized trial, and was 0.8% and 6.2% in two observational studies. The incidence of asymptomaticVTE ranged from 3.7% to 26.0% (median 12.8%). Risk factors identified were older age, prior VTE, and obesity. Though there is little high quality evidence, the best estimate of the incidence of hospital-acquired VTE for general medical patients is approximately 2% for patients at moderate to high risk and < 1% for patients at low risk. Further studies are needed to more precisely define a low risk group for whom anticoagulant prophylaxis is unnecessary.
引用
收藏
页码:758 / 762
页数:5
相关论文
共 13 条
[1]
PREVENTION OF DEEP-VEIN THROMBOSIS IN MEDICAL PATIENTS BY LOW-DOSE HEPARIN [J].
BELCH, JJ ;
LOWE, GDO ;
WARD, AG ;
FORBES, CD ;
PRENTICE, CRM .
SCOTTISH MEDICAL JOURNAL, 1981, 26 (02) :115-117
[2]
COHEN AT, 2003, BLOOD, V102
[3]
Venous thromboembolism in medical inpatients:: Prophylaxis with low-weight heparin in a university hospital and prevalence of thromboembolic events [J].
Dhôte, R ;
Pellicer-Coeuret, M ;
Belouet-Moreau, C ;
Christoforov, B ;
Vidal-Trecan, G .
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2001, 7 (01) :16-20
[4]
Gardlund B, 1996, LANCET, V347, P1357
[5]
Prevention of venous thromboembolism [J].
Geerts, WH ;
Pineo, GF ;
Heit, JA ;
Bergqvist, D ;
Lassen, MR ;
Colwell, CW ;
Ray, JG .
CHEST, 2004, 126 (03) :338S-400S
[6]
KIERKEGAARD A, 1987, ACTA MED SCAND, V222, P409
[7]
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients [J].
Leizorovicz, A ;
Cohen, AT ;
Turpie, AGG ;
Olsson, CG ;
Vaitkus, PT ;
Goldhaber, SZ .
CIRCULATION, 2004, 110 (07) :874-879
[8]
LOSITO R, 1981, J LAB CLIN MED, V97, P241
[9]
Retrospective database analysis of the prevention of venous thromboembolism with low-molecular-weight heparin in acutely ill medical inpatients in community practice [J].
McGarry, LJ ;
Thompson, D .
CLINICAL THERAPEUTICS, 2004, 26 (03) :419-430
[10]
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials [J].
Moher, D ;
Schulz, KF ;
Altman, DG .
LANCET, 2001, 357 (9263) :1191-1194